<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>2007-4085</journal-id>
<journal-title><![CDATA[Revista mexicana de urología]]></journal-title>
<abbrev-journal-title><![CDATA[Rev. mex. urol.]]></abbrev-journal-title>
<issn>2007-4085</issn>
<publisher>
<publisher-name><![CDATA[Sociedad Mexicana de Urología]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S2007-40852021000500005</article-id>
<article-id pub-id-type="doi">10.48193/revistamexicanadeurologa.v81i5.737</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Linfoma no-Hodgkin testicular primario. Revisión de la literatura y reporte de caso]]></article-title>
<article-title xml:lang="en"><![CDATA[Primary non-Hodgkin testicular lymphoma. Literature review and case report]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[García-Manzano]]></surname>
<given-names><![CDATA[Roberto Armando]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Vásquez-Ciriaco]]></surname>
<given-names><![CDATA[Sergio]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Dávila-Ruiz]]></surname>
<given-names><![CDATA[Ediel Osvaldo]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Martínez-Santiago]]></surname>
<given-names><![CDATA[Nallely Ytandehui]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Barker-Antonio]]></surname>
<given-names><![CDATA[Alan]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Escamilla-Orzuna]]></surname>
<given-names><![CDATA[Kenia]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Morales-Chairez]]></surname>
<given-names><![CDATA[Victoria]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Arrecillas-Zamora]]></surname>
<given-names><![CDATA[Mirna]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Secretaría de Salud Hospital Regional de Alta Especialidad de Oaxaca ]]></institution>
<addr-line><![CDATA[ Oaxaca]]></addr-line>
<country>México</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>10</month>
<year>2021</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>10</month>
<year>2021</year>
</pub-date>
<volume>81</volume>
<numero>5</numero>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_arttext&amp;pid=S2007-40852021000500005&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_abstract&amp;pid=S2007-40852021000500005&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_pdf&amp;pid=S2007-40852021000500005&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[Resumen  Caso clínico:  Masculino de 88 años con diagnóstico clínico y ecográfico de hidrocele izquierdo, tratado con orquiectomía radical con reporte inmunohistoquímico de linfoma no-Hodgkin difuso de células grandes inmunofenotipo B en actual tratamiento a base de quimioterapia.  Relevancia:  En México el linfoma primario testicular es raro, en nuestra institución es el primer caso reportado. En el 43% de los casos se presenta asociado a patología benigna como hidrocele u orquiepididimitis que dificultad la sospecha en etiología maligna, teniendo en cuenta que el diagnóstico oportuno y el tratamiento expedito es de vital importancia para el pronóstico.  Implicaciones clínicas:  Esta entidad poco frecuente, requiere alto índice de sospecha clínica ante patología testicular en un contexto de pacientes mayores de 50 años, con o sin síntomas consuntivos. Se considera una enfermedad agresiva con un mal pronóstico por su alto índice de recaídas a sitios extra ganglionares y a sistema nervioso central.  Discusión y conclusión:  El linfoma testicular primario es una neoplasia rara con una incidencia anual de 0.26 casos por 100 000 personas-año, La edad media de presentación es de 60 años, presenta expresión clínica poco específica con diagnóstico definitivo por inmunohistoquímica. El tratamiento multimodal ha demostrado mejoría pronóstico de esta entidad.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract  Clinical case:  An 88-year-old male with a clinical and ultrasound diagnosis of a left hydrocele, treated with radical orchiectomy with an immunohistochemical report of diffuse large cell immunophenotype B non-Hodgkin's lymphoma under current chemotherapy-based treatment.  Relevance:  In Mexico, primary testicular lymphoma is rare, in our institution it is the first reported case. In 43% of cases, it is associated with benign pathology such as hydrocele or epididymo-orchitis, which makes it difficult to suspect a malignant etiology, taking into account that timely diagnosis and prompt treatment is of vital importance for prognosis.  Clinical implications:  This rare entity requires a high index of clinical suspicion for testicular pathology in the context of patients over 50 years of age, with or without consumptive symptoms. It is considered an aggressive disease with a poor prognosis due to its high relapse rate to extranodal sites and the central nervous system.  Discussion and conclusion:  Primary testicular lymphoma is a rare neoplasm with an annual incidence of 0.26 cases per 100,000 person-years, the mean age of presentation is 60 years, it presents unspecific clinical expression with definitive diagnosis by immunohistochemistry. Multimodal treatment has shown an improvement in the prognosis of this entity.]]></p></abstract>
<kwd-group>
<kwd lng="en"><![CDATA[Testicular cancer]]></kwd>
<kwd lng="en"><![CDATA[non-Hodgkin lymphoma]]></kwd>
<kwd lng="en"><![CDATA[extranodal lymphoma]]></kwd>
<kwd lng="es"><![CDATA[Cáncer testicular]]></kwd>
<kwd lng="es"><![CDATA[linfoma no-Hodgkin]]></kwd>
<kwd lng="es"><![CDATA[linfoma extranodal]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hennessy]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Hanrahan]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Daly]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Non-Hodgkin lymphoma: an update]]></article-title>
<source><![CDATA[Lancet Oncol]]></source>
<year>2004</year>
<volume>5</volume>
<page-range>341-53</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Busto-Martín]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Pombo-Otero]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Busto-Castañon]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Presentación testicular de un Linfoma no Hodgkin Tipo NK Nasal]]></article-title>
<source><![CDATA[Rev Mex Urol]]></source>
<year>2011</year>
<volume>71</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>110-06</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gómez]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Rodríguez]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Sanz]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Rodríguez]]></surname>
<given-names><![CDATA[JM]]></given-names>
</name>
<name>
<surname><![CDATA[Palmeiro]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Conde]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Linfoma Tasticular primario. Aportación de un Nuevo caso y revision de la literatura]]></article-title>
<source><![CDATA[Actas Urol Esp]]></source>
<year>2004</year>
<volume>28</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>141-6</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Vannata]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Zucca]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Primary extranodal B-cell lymphoma: current concepts and treatment strategies]]></article-title>
<source><![CDATA[Chin Clin Oncol]]></source>
<year>2015</year>
<volume>4</volume>
<page-range>10</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Trujillo-Ortiza]]></surname>
<given-names><![CDATA[L.]]></given-names>
</name>
<name>
<surname><![CDATA[Camacho-Castroa]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
<name>
<surname><![CDATA[Muñoz-Ibarraa]]></surname>
<given-names><![CDATA[E.L.]]></given-names>
</name>
<name>
<surname><![CDATA[García-Salcidoa]]></surname>
<given-names><![CDATA[F.]]></given-names>
</name>
<name>
<surname><![CDATA[Garza-Sainza]]></surname>
<given-names><![CDATA[G.]]></given-names>
</name>
<name>
<surname><![CDATA[sornio-Sánchez]]></surname>
<given-names><![CDATA[V.O]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Tumor testicular bilateral, tipo linfoma no Hodgkin de células T/NK extranasal]]></article-title>
<source><![CDATA[Rev Mex Urol]]></source>
<year>2014</year>
<volume>74</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>250-25</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Talerman]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Primary malignant lymphoma of the testis]]></article-title>
<source><![CDATA[J Urol]]></source>
<year>1977</year>
<volume>118</volume>
<page-range>783-6</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Twa]]></surname>
<given-names><![CDATA[DDW]]></given-names>
</name>
<name>
<surname><![CDATA[Mottok]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Savage]]></surname>
<given-names><![CDATA[KJ]]></given-names>
</name>
<name>
<surname><![CDATA[Steidl]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The pathobiology of primary testicular diffuse large B-cell lymphoma: Implications for novel therapies]]></article-title>
<source><![CDATA[Blood Rev]]></source>
<year>2018</year>
<volume>32</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>249&#8208;255</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Moty&#269;ková]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Vosáhlová]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Belada]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[&#352;imkovi&#269;]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[&#381;ák]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Primární testikulární lymfomy [Primary testicular lymphoma]]]></article-title>
<source><![CDATA[Vnitr Lek]]></source>
<year>2017</year>
<volume>63</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>415-22</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Klapper]]></surname>
<given-names><![CDATA[W]]></given-names>
</name>
<name>
<surname><![CDATA[Stoecklein]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Zeynalova]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Structural aberrations affecting the MYC locus indicate a poor prognosis independent of clinical risk factors in diffuse large B-cell lymphomas treated within randomized trials of the German High-Grade Non-Hodgkin&#8217;s Lymphoma Study Group (DSHNHL)]]></article-title>
<source><![CDATA[Leukemia]]></source>
<year>2008</year>
<volume>22</volume>
<page-range>2226-9</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ferry]]></surname>
<given-names><![CDATA[JA]]></given-names>
</name>
<name>
<surname><![CDATA[Harris]]></surname>
<given-names><![CDATA[NL]]></given-names>
</name>
<name>
<surname><![CDATA[Young]]></surname>
<given-names><![CDATA[RH]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Malignant lymphoma of the testis, epididymis, and spermatic cord. A clinicopathologic study of 69 cases with immunophenotypic analysis]]></article-title>
<source><![CDATA[Am J Surg Pathol]]></source>
<year>1994</year>
<volume>18</volume>
<page-range>376-90</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Vitolo]]></surname>
<given-names><![CDATA[U]]></given-names>
</name>
<name>
<surname><![CDATA[Ferreri]]></surname>
<given-names><![CDATA[AJ]]></given-names>
</name>
<name>
<surname><![CDATA[Zucca]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Primary testicular lymphoma]]></article-title>
<source><![CDATA[Crit Rev Oncol Hematol]]></source>
<year>2008</year>
<volume>65</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>183-9</page-range></nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mazzu]]></surname>
<given-names><![CDATA[DR]]></given-names>
</name>
<name>
<surname><![CDATA[Jeffrey]]></surname>
<given-names><![CDATA[Jr]]></given-names>
</name>
<name>
<surname><![CDATA[Ralls]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Lymphoma and leukaemia involving the testicles: findings on gray scale and color Doppler sonography]]></article-title>
<source><![CDATA[Am. 1. Roentgenol]]></source>
<year>1995</year>
<page-range>164-645</page-range></nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Shahab]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Doll]]></surname>
<given-names><![CDATA[DC]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Testicular lymphoma]]></article-title>
<source><![CDATA[Semin Oncol]]></source>
<year>1999</year>
<volume>26</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>259-69</page-range></nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Fonseca]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Habermann]]></surname>
<given-names><![CDATA[TM]]></given-names>
</name>
<name>
<surname><![CDATA[Colgan]]></surname>
<given-names><![CDATA[JP]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Testicular lymphoma is associated with a high incidence of extranodal recurrence]]></article-title>
<source><![CDATA[Cancer]]></source>
<year>2000</year>
<volume>88</volume>
<page-range>154-61</page-range></nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Candelaria]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Oñate-Ocaña]]></surname>
<given-names><![CDATA[LF]]></given-names>
</name>
<name>
<surname><![CDATA[Corona-Herrera]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Clinical characteristics of primary extranodal versus nodal diffuse large b-cell lymphoma: a retrospective cohort study in a cancer center]]></article-title>
<source><![CDATA[Rev Invest Clin]]></source>
<year>2019</year>
<volume>71</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>349-58</page-range></nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Zucca]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Conconi]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Mughal]]></surname>
<given-names><![CDATA[TI]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Patterns of outcome and prognostic factors in primary large-cell lymphoma of the testis in a survey by the International Extranodal Lymphoma Study Group]]></article-title>
<source><![CDATA[J Clin Oncol]]></source>
<year>2003</year>
<volume>21</volume>
<page-range>20-7</page-range></nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mazloom]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Fowler]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Medeiros]]></surname>
<given-names><![CDATA[LJ]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Outcome of patients with diffuse large B-cell lymphoma of the testis by era of treatment: the M. D. Anderson Cancer Center experience]]></article-title>
<source><![CDATA[Leuk Lymphoma]]></source>
<year>2010</year>
<volume>51</volume>
<page-range>1217-24</page-range></nlm-citation>
</ref>
<ref id="B18">
<label>18</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kridel]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Telio]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Villa]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Diffuse large B-cell lymphoma with testicular involvement: outcome and risk of CNS relapse in the rituximab era]]></article-title>
<source><![CDATA[Br J Haematol]]></source>
<year>2016</year>
<volume>176</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>210-21</page-range></nlm-citation>
</ref>
<ref id="B19">
<label>19</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Autorino]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Lamendola]]></surname>
<given-names><![CDATA[MG]]></given-names>
</name>
<name>
<surname><![CDATA[De Sio]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Di Trolio]]></surname>
<given-names><![CDATA[RA]]></given-names>
</name>
<name>
<surname><![CDATA[Ferraraccio]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Di Lorenzo]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[A complete response with rituximab in metastatic diffuse large B-cell lymphoma of the testis: case report]]></article-title>
<source><![CDATA[Int J Immunopathol Pharmacol]]></source>
<year>2007</year>
<volume>20</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>401-3</page-range></nlm-citation>
</ref>
<ref id="B20">
<label>20</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lister]]></surname>
<given-names><![CDATA[TA]]></given-names>
</name>
<name>
<surname><![CDATA[Crowther]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Sutcliffe]]></surname>
<given-names><![CDATA[SB]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin&#8217;s disease: Cotswolds meeting]]></article-title>
<source><![CDATA[J Clin Oncol]]></source>
<year>1989</year>
<volume>7</volume>
<page-range>1630-6</page-range></nlm-citation>
</ref>
<ref id="B21">
<label>21</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Wang]]></surname>
<given-names><![CDATA[Q]]></given-names>
</name>
<name>
<surname><![CDATA[Zheng]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Chai]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Wu]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Wang]]></surname>
<given-names><![CDATA[X]]></given-names>
</name>
<name>
<surname><![CDATA[Chen]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Wu]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Cao]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Tao]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Primary testicular diffuse large B-cell lymphoma: Case series]]></article-title>
<source><![CDATA[Medicine (Baltimore)]]></source>
<year>2020</year>
<volume>99</volume>
<numero>12</numero>
<issue>12</issue>
</nlm-citation>
</ref>
<ref id="B22">
<label>22</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[McLaughlin]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Grillo Lopez]]></surname>
<given-names><![CDATA[A.J.]]></given-names>
</name>
<name>
<surname><![CDATA[Link]]></surname>
<given-names><![CDATA[B.K.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma. Half of patients respond to a four-dose treatment program]]></article-title>
<source><![CDATA[1. Clin. Oneal]]></source>
<year>1998</year>
<volume>16</volume>
<numero>2825</numero>
<issue>2825</issue>
</nlm-citation>
</ref>
<ref id="B23">
<label>23</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Andhavarapu]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Crozier]]></surname>
<given-names><![CDATA[JA]]></given-names>
</name>
<name>
<surname><![CDATA[Jiang]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Sher]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Mantle cell lymphoma and diffuse large B-cell lymphoma of the testis: a unique case of composite non-Hodgkin lymphoma]]></article-title>
<source><![CDATA[Eur J Haematol]]></source>
<year>2014</year>
<volume>93</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>537-42</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
